Current OI Studies

Banner_ResearchGrantOpportunities_new

SHARE

In This Article
    Add a header to begin generating the table of contents

    Current OI Studies

    SHARE

    Icon_FB_blue Icon_X_blue Icon_LinkedIn_blue Icon_email_blue

    Why you should participate

    Participation in OI research helps advance the scientific understanding of OI so that more and better treatments can be made available to the OI community. Take a look at OI studies and recent OI publications below.

    Supporting research is an important part of the OI Foundation’s mission. Often, the success of clinical studies of a rare disorder like osteogenesis imperfecta (OI) depends on getting enough people to participate in the study so the results are meaningful. People who are interested in participating in a clinical trial are encouraged to review the fact sheet What You Need to Know about Clinical Trials. Additional information about research studies can be found on www.clinicaltrials.gov.

    The following studies are currently enrolling participants:

    Disclaimer: The OI Foundation is not involved in the design or management of this research, and as such, is neither endorsing nor supporting these studies. The mission of the OIF is to keep the OI community informed of all relevant studies. This information is made available as a service to the OI community.

    Interested in learning more about participating in Clinical Trials?

    Take a look at the OI Foundation’s What You Need To Know About Clinical Trials Factsheet.

    Helping our community stay up to date and connected.

    Please sign up to receive updates from the OI Foundation including our monthly e-Newsletter, research updates, and upcoming event information.

    Subscribe to the OIF Newsletter

    * indicates required

    SUBSCRIBE Main_Subscribe

    Helping our community stay up to date and connected.

    Please sign up to receive updates from the OI Foundation including our monthly e-Newsletter, research updates, and upcoming event information.

    Main_Subscribe